Benekos, Konstantinos
Katsanos, Andreas
Laspas, Panagiotis
Panos, Georgios D.
Vagiakis, Iordanis
Fousekis, Fotios S.
Luca, Robert
Zhou, Beryl
Kostoulas, Charilaos
Georgiou, Ioannis
Katsanos, Konstantinos H.
Skondra, Dimitra
Konstas, Anastasios G.
Article History
Received: 3 March 2026
Accepted: 20 April 2026
First Online: 19 May 2026
Declarations
Conflict of Interest: Konstantinos Benekos, Panagiotis Laspas, Konstantinos H. Katsanos, Fotios S. Fousekis, Georgios D. Panos, Charilaos Kostoulas, Ioannis Georgiou, Robert Luca, Beryl Zhou have nothing to disclose; Prof Andreas Katsanos: research funding from Théa, fees for consultancy and lectures with travel support from Vianex, Laboratoires Théa; congress expenses: Cooper. Iordanis Vagiakis: travel support from Vianex; Prof Dimitra Skondra: consultant/advisory board with Abbvie, Eyepoint, Biogen, Boehringer, Regeneron; Anastasios G. Konstas: research funding from Bayer, Omni Vision, Santen and Théa; fees for consultancy and lectures with travel support from Esteve, Intermed, Santen, Théa and Vianex. Anastasios G. Konstas is an Editorial Board member of Advances in Therapy. Anastasios G. Konstas was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
Ethical Approval: This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.